Bisac-evac
Loading...Bisac-evac Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For rectal use only
Do not use laxative products for a period longer than one week unless directed by a doctor
Ask a doctor before use if you have
• abdominal pain, nausea or vomiting
• a sudden change in bowel habits that lasts longer than 2 weeks
Stop use and ask a doctor if rectal bleeding occurs or you fail to have a bowel movement after using a laxative. These may be signs of a serious condition.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For the relief of occasional constipation.
Bowel movement is generally produced in 15 minutes to 1 hour.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Bisac-evac Manufacturers
-
G&w Laboratories, Inc.
![Bisac-evac (Bisacodyl) Suppository [G&w Laboratories, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Bisac-evac | G&w Laboratories, Inc.
• see chart below for dose
• remove foil wrapper
• insert suppository well up into the rectum as indicated, and retain it about 15 to 20 minutesadults and children 12 years and over
1 suppository once daily.
children 6 years to under 12 years
1/2 suppository once daily
children under 6 years
ask a doctor
• In the presence of anal fissures or hemorrhoids, suppositories should be coated at the tip with petroleum jelly.
-
Cardinal Health
Bisac-evac | Teva Pharmaceuticals Usa Inc
Carefully consider the potential benefits and risks of etodolac tablets and other treatment options before deciding to use etodolac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).
After observing the response to initial therapy with etodolac tablets, the dose and frequency should be adjusted to suit an individual patient's needs.
Dosage adjustment of etodolac tablets is generally not required in patients with mild to moderate renal impairment. Etodolac tablets should be used with caution in such patients, because, as with other NSAIDs, they may further decrease renal function in some patients with impaired renal function (see WARNINGS, Renal Effects).
AnalgesiaThe recommended total daily dose of etodolac tablets for acute pain is up to 1,000 mg, given as 200 to 400 mg every 6 to 8 hours. Doses of etodolac greater than 1,000 mg/day have not been adequately evaluated in well-controlled clinical trials.
Osteoarthritis and Rheumatoid ArthritisThe recommended starting dose of etodolac tablets for the management of the signs and symptoms of osteoarthritis or rheumatoid arthritis is: 300 mg b.i.d., t.i.d., or 400 mg b.i.d., or 500 mg b.i.d. A lower dose of 600 mg/day may suffice for long-term administration. Physicians should be aware that doses above 1,000 mg/day have not been adequately evaluated in well-controlled clinical trials.
In chronic conditions, a therapeutic response to therapy with etodolac tablets is sometimes seen within one week of therapy, but most often is observed by two weeks. After a satisfactory response has been achieved, the patient’s dose should be reviewed and adjusted as required.
![Bisac-evac (Bisacodyl) Suppository [Cardinal Health]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=58340508-b1cb-4607-9158-f2b3700accba&name=image-02.jpg)
Login To Your Free Account